drugset / Trial / NCT01394653

A Study to Compare Oral Absorption of YM060 Between Orally-disintegrating Tablet and Conventional Tablet Under With Water Intake

NCT01394653

Phase 1 Completed 36 enrolled Astellas Pharma Inc
RandomizedCrossoverOpen-label

Summary

A study to compare time-course changes of plasma concentration of YM060 orally-disintegrating tablet with those of conventional tablet. Tablets will be administered with water.

Timeline

Start
2011-07
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Ramosetron Small molecule Oral

Indications

No indication recorded.